Broad dengue neutralization in mosquitoes expressing an engineered antibody.

Broad dengue neutralization in mosquitoes expressing an engineered antibody.

With dengue virus (DENV) becoming endemic in tropical and subtropical regions worldwide, there is a pressing global demand for effective strategies to control the mosquitoes that spread this disease. Recent advances in genetic engineering technologies have made it possible to create mosquitoes with...

Full description

Bibliographic Details
Main Authors:	Anna Buchman, Stephanie Gamez, Ming Li, Igor Antoshechkin, Hsing-Han Li, Hsin-Wei Wang, Chun-Hong Chen, Melissa J Klein, Jean-Bernard Duchemin, James E Crowe, Prasad N Paradkar, Omar S Akbari
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS Pathogens
Online Access:	https://doi.org/10.1371/journal.ppat.1008103

Similar Items

Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody.
by: Anna Buchman, et al.
Published: (2020-04-01)

Iron availability affects West Nile virus infection in its mosquito vector
by: Jean-Bernard Duchemin, et al.
Published: (2017-06-01)

Assessment of ICount software, a precise and fast egg counting tool for the mosquito vector Aedes aegypti
by: Julie Gaburro, et al.
Published: (2016-11-01)

Cullin4 Is Pro-Viral during West Nile Virus Infection of Culex Mosquitoes.
by: Prasad N Paradkar, et al.
Published: (2015-09-01)

Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
by: Wong, Yee Hwa, et al.
Published: (2018)

Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
by: Wong, Yee Hwa, et al.
Published: (2018)

Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody
by: Wen-Fan Shen, et al.
Published: (2018-10-01)

Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
by: Natasha D Durham, et al.
Published: (2019-12-01)

The Developmental Transcriptome of Aedes albopictus, a Major Worldwide Human Disease Vector
by: Stephanie Gamez, et al.
Published: (2020-03-01)

Convergent antibody responses are associated with broad neutralization of hepatitis C virus
by: Nicole E. Skinner, et al.
Published: (2023-03-01)

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III.
by: Dan Hu, et al.
Published: (2019-06-01)

Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development
by: Charles D. Murin, et al.
Published: (2022-01-01)

Releasing Intracellular NS1 from Mosquito Cells for the Detection of Dengue Virus-Infected Mosquitoes
by: Lie Cheng, et al.
Published: (2020-09-01)

Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus
by: Nicole E. Skinner, et al.
Published: (2023-04-01)

Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus
by: Gielenny M. Salem, et al.
Published: (2024-01-01)

Whole Transcriptome Analysis of <i>Aedes albopictus</i> Mosquito Head and Thorax Post-Chikungunya Virus Infection
by: Ravi kiran Vedururu, et al.
Published: (2019-08-01)

The expanding array of HIV broadly neutralizing antibodies
by: Laura E. McCoy
Published: (2018-10-01)

Broadly Neutralizing Antibodies for HIV-1 Prevention
by: Stephen R. Walsh, et al.
Published: (2021-07-01)

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
by: Dejnirattisai, W, et al.
Published: (2014)

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
by: Dejnirattisai, W, et al.
Published: (2014)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
by: Elise Landais, et al.
Published: (2018-09-01)

Antibody affinity versus dengue morphology influences neutralization.
by: Guntur Fibriansah, et al.
Published: (2021-02-01)

Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
by: Yubin Liu, et al.
Published: (2020-01-01)

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
by: Colin LaMont, et al.
Published: (2022-07-01)

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
by: Zhigang Zhang, et al.
Published: (2021-03-01)

Author Correction: Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus
by: Gielenny M. Salem, et al.
Published: (2024-03-01)

Contribution of rare mutational outcomes to broadly neutralizing antibodies
by: Feng Anqi, et al.
Published: (2022-06-01)

Optimizing immunization protocols to elicit broadly neutralizing antibodies
by: Sprenger, Kayla G, et al.
Published: (2021)

Cross-reactive broadly neutralizing antibodies: timing is everything
by: Zelda eEuler, et al.
Published: (2012-07-01)

Broadly neutralizing antibodies in HIV-1 treatment and prevention
by: Rajesh Kumar, et al.
Published: (2018-08-01)

Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy of dengue vaccine
by: Tsai, W, et al.
Published: (2018)

Dicer-2-dependent activation of Culex Vago occurs via the TRAF-Rel2 signaling pathway.
by: Prasad N Paradkar, et al.
Published: (2014-04-01)

Origin of the dengue fever mosquito, Aedes aegypti, in California.
by: Andrea Gloria-Soria, et al.
Published: (2014-01-01)

Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies
by: Karplus, Martin, et al.
Published: (2018)

Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies
by: Victor Ovchinnikov, et al.
Published: (2018-02-01)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
by: Haynes, BF, et al.
Published: (2022)

Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
by: Mrityunjoy Biswas, et al.
Published: (2020-07-01)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
by: Sarah Wilmschen, et al.
Published: (2019-09-01)

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
by: Jérémy Dufloo, et al.
Published: (2018-07-01)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
by: Timothée Bruel, et al.
Published: (2016-03-01)